SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

DJ Angion Biomedica IPO Priced at High End of Expectations >ANGN

· 02/05/2021 08:41

By Colin Kellaher

Angion Biomedica Corp. Friday said its initial public offering of 5 million shares was priced at $16 apiece, at the top of the expected range of $14 to $16.

The Uniondale, N.Y., late-stage biopharmaceutical company said it expects gross proceeds of $80 million, adding that it granted the underwriters a 30-day option to buy up to an additional 750,000 shares.

Angion shares are due to begin trading Friday under the symbol ANGN.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

February 05, 2021 08:41 ET (13:41 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.